June 1, 2012
Multilateral Instrument 51-105, Issuers Quoted in the U.S. Over-the-Counter Markets will come into effect on July 31, 2012. Once effective, issuers whose securities trade in over-the-counter markets in the United States may become subject to enhanced disclosure requirements and resale restrictions under Canadian securities laws.
With the effective date of the Instrument approaching, issuers who are currently listed or plan to list on an over-the-counter market in the future should consider the implications of the Instrument.
INTRODUCTION AND BACKGROUND
On May 10, 2012, the Canadian Securities Administrators (“CSA”) announced the adoption of Multilateral Instrument 51-105, Issuers Quoted in the U.S. Over-the-Counter Markets (the “Instrument”) by all Canadian securities regulators, with the exception of the Ontario Securities Commission. The Instrument will come into effect on July 31, 2012.
The CSA has stated that it is appropriate for issuers who have a significant connection with a Canadian jurisdiction to make disclosure to the same standard as Canadian reporting issuers. The Instrument, which is based on BC Instrument 51-509, Issuers Quoted in the U.S. Over-the-Counter Markets, is being introduced to meet this objective.
APPLICATION OF THE INSTRUMENT
The Instrument applies to issuers (“OTC issuer”) who have issued a class of securities that has been assigned a ticker symbol for use on an over-the-counter (“OTC”) market, including a grey market, in the United States (except for issuers concurrently listed on designated stock exchanges, including the Toronto Stock Exchange, TSX Venture Exchange, the New York Stock Exchange, the NYSE Amex and the NASDAQ Stock Market) and has a significant connection to a local Canadian jurisdiction that has adopted the Instrument. A “significant connection” will be established if one or more of the following applies:
An OTC issuer and its insiders will be subject to enhanced disclosure requirements and, in some cases, restrictions on trading in the issuer’s securities.
If an issuer becomes an OTC issuer pursuant to the Instrument, it is required to comply with the Instrument for at least one year. Following that year, the issuer may file a notice in order to cease the application of the Instrument, unless the issuer continues to direct or administer its business or carry on promotional activities in a Canadian jurisdiction where the Instrument is in force.
DISCLOSURE AND FILING REQUIREMENTS
An OTC issuer is required to adhere to the disclosure requirements for reporting issuers and their insiders set out in Canadian securities legislation.
Pursuant to the Instrument, OTC issuers must:
Generally speaking, other than the requirement to file an AIF, OTC issuers will be treated as “venture issuers” (as defined in NI 51-102) for the purposes of disclosure requirements.
OTC issuers that file disclosure with the U.S. Securities and Exchange Commission (“SEC”) are able to comply with the Instrument by filing financial statements, material change reports, MD&A and AIFs using documents they file with the SEC.
ADDITIONAL FILING REQUIREMENTS
The Instrument also provides for the filing of:
While OTC issuers are required to comply with enhanced disclosure requirements, mining issuers are relieved from a particularly onerous requirement under Canadian securities law: despite National Instrument 43-101, Standards of Disclosure for Mineral Projects, they are not required to file a technical report upon becoming subject to the Instrument. OTC issuers in the oil and gas sector, however, must comply with National Instrument 51-101, Standards of Disclosure for Oil and Gas Activities for financial years beginning on or after January 1, 2012.
In order to deter the transfer, for abusive purposes, to buyers of shell companies of the “public float” of such shell companies which has been created from shares sold in private placements to Canadian residents, the Instrument imposes restrictions on the sale of seed stock. In general, the Instrument:
For securities that are acquired after the date of receiving a ticker symbol and in reliance on an exemption from prospectus requirements, there are resale restrictions similar to those imposed on the securities of Canadian reporting issuers. In addition, the Instrument includes specified legend requirements, additional holding periods for control persons and a limit on the number of securities that may be traded within a 12-month period.
Despite the restrictions on trades subject to the Instrument, there are specified exceptions to these restrictions, including for trades of securities made in connection with take-over or issuer bids, mergers or reorganizations, or the dissolution of the issuer.
TRANSITION TO THE INSTRUMENT
The Instrument includes limited transition provisions, which apply in all relevant jurisdictions except British Columbia, for financial disclosure by non-SEC filers and for oil and gas disclosure. For remaining OTC issuers (and in British Columbia), there is no transition period and these issuers will be subject to all requirements of the Instrument beginning on July 31, 2012. The first annual and quarterly filings under the Instrument for these OTC issuers will require reporting for periods prior to July 31, 2012.
FEES AND COSTS OF IMPLEMENTATION
OTC issuers and their insiders will be required to pay the same filing fees as other reporting issuers in Canada, which includes SEDAR filing fees and late filing penalties.
COSTS OF IMPLEMENTATION
It is not expected that compliance with the disclosure requirements in the Instrument will be costly for OTC issuers, so long as they are currently SEC filers. However, the CSA has acknowledged that OTC issuers who are not SEC filers may incur significant costs to comply with the Instrument, particularly if these issuers do not currently have audited financial statements.
Jul 27, 2021
Canadian entities regularly contract with foreign companies to provide services in Canada. To complete its obligations under the contract, the…
Jul 21, 2021
Many now agree: it’s imperative that workplaces be both diverse and inclusive. Perhaps the most often-quoted (and definitely most succinct)…
Jun 24, 2021
Many employers use equity compensation plans like employee stock option plans to attract, motivate, and retain talent. One reason stock options…
Jun 21, 2021
There is a duty to consult Indigenous groups when the Crown contemplates actions that may adversely affect their rights under section 35 of the…
Jun 15, 2021
As of January 1, 2021, federally regulated employers (such as banks, telephone and cable systems, most federal Crown corporations,…
Subscribe to McInnes Cooper to stay current with our leading insights on legal updates, trends, news, events, and services.